Lok Sabha Question No. 134 (STARRED), answered on 2016-07-26
Subject: Trade in Generic Pharmaceuticals
Ministry: CHEMICALS AND FERTILIZERS
Asked by: George Baker

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

## LOK SABHA

## STARRED QUESTION No. 134

## TO BE ANSWERED ON THE 26 th  July, 2016

## Trade in Generic Pharmaceuticals

- *134. SHRI GEORGE BAKER:

Will  the  Minister  of  CHEMICALS  AND  FERTILIZERS  be  pleased  to state:

- (a) the  details  of  India's  share  in  the  global  trade  of  generic pharmaceuticals;
- (b) the total quantity and value of production of generic pharmaceuticals  along  with  the  quantity  and  value  of  such products exported and imported during the last three years and the current year, category-wise;
- (c) the share of generic and non-generic medicines to the total sales of medicines in the country including the Government hospitals; and
- (d) the  steps  taken  by  the  Government  to  promote  use  of generic medicines including compulsory prescription of generic  medicines  by  doctors  and  the  outcome  of  such steps, if any?

## ANSWER

## (MINISTER  IN  THE  MINISRY  OF  CHEMICALS  AND  FERTILIZERS AND PARLIAMENTARY AFFAIRS SHRI ANANTHKUMAR)

- (a) to (d): A statement is laid on the Table of the House.

## Statement referred to reply to LOK SABHA STARRED QUESTION No. 134  TO  BE  ANSWERED ON THE 26 th   July,  2016  regarding  Trade  in Generic Pharmaceuticals (14 th Position)

- (a): For  the  year  2015,  India's  share  of  global  trade  of  generics  was about  8.8%  on  account  of  25.6  billion  USD  of  Indian  generic market in the global generic market of 290 billion USD.
- (b): Information  about  the  total  quantity  and  value  of  production  of generics is not available. India's  total exports  &  imports  of  drugs and pharmaceuticals, which primarily includes generics in terms of quantity and value for last 3 year and current year is as under:-
- (c): No exact  information  about  the  percentage  share  of  non-generic medicine  is  available.  However,  as  per  the  estimates  by  India Brand  Equity  Fund  (IBEF),  9%  of  the  domestic  market  was  on account of non-generic drugs.
- (d): The para 1.5 of the Indian Medical Council (Professional conduct, Etiquette  and  Ethics)  Regulations,  2002  provides  that  'Every physician should, as far as possible, prescribe drugs with generic names and he/she shall ensure that there is a rational prescription and use of drugs'.

|                        | EXPORT DATA     | EXPORT DATA      | IMPORT DATA     | IMPORT DATA      |
|------------------------|-----------------|------------------|-----------------|------------------|
| Year                   | Quantity in kgs | Rupees in crores | Quantity in kgs | Rupees in crores |
| 2013-14                | 380912668       | 67403.71         | 4647421         | 9371.38          |
| 2014-15                | 443939604       | 70815.1          | 5954402         | 9961.29          |
| 2015-16                | 399231919       | 84465.98         | 6495009         | 10742.07         |
| 2016-17 (Apr-May 2016) | 72711464        | 13950.11         | 804142          | 1698.13          |

Besides,  to  promote  consumption  of  generic  medicines,  a countrywide campaign for ensuring availability of generic medicines  at  affordable  prices  to  all,  in  the  name  of  'Pradhan Mantri Jan Aushadhi Yojana (PMJAY)', has been launched by the Department  of  Pharmaceuticals  and  these  generic  drugs  are available at 'Jan Aushadhi Stores' run by Bureau of Pharmaceuticals  of  PSUs  of  India  (BPPI)  under  the  Pradhan Mantri Jan Aushadhi Yojana.